Haloperidol for control of severe emotional reactions in mentally retarded patients.
D000293:Adolescent; D000342:Affective Symptoms / Q000188:drug therapy* / Q000209:etiology; D001288:Attention / Q000187:drug effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D001590:Benztropine / Q000627:therapeutic use; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy* / Q000209:etiology; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008607:Intellectual Disability / Q000150:complications / Q000534:rehabilitation*; D007858:Learning / Q000187:drug effects; D008297:Male
D001590:Benztropine; D006220:Haloperidol